Alpha-nicotinic acetylcholine receptor and tobacco smoke exposure: effects on bronchial hyperresponsiveness in children.
BACKGROUND
The CHRNA 3 and 5 genes on chromosome 15 encode the alpha subunits of the nicotinic acetylcholine receptor, mediating airway cholinergic activity. Polymorphisms are associated with cigarette smoking, chronic obstructive pulmonary disease, and lung cancer.


OBJECTIVE
To determine possible associations between CHRNA 3/5 SNP rs8034191 and asthma or lung function in children in one local and one replicate multinational population, and assess if tobacco smoke modified the associations.


METHODS
The rs8034191 SNP genotyped in 551 children from the environment and childhood asthma (ECA) birth cohort study in Oslo, Norway, and in 516 families from six European centers [the Genetics of Asthma International Network (GAIN) study] was tested for genotypic or allelic associations to current or history of asthma, allergic sensitization (≥ one positive skin prick tests), bronchial hyperresponsiveness (BHR), and lung function (FEV(1%) of predicted and FEV(1) /FVC ratio over/ below the 5th percentile).


RESULTS
Although the TT and CT genotypes at SNP rs 8034191 were overall significantly associated with BHR (OR = 3.9, 95% CI 1.5-10.0, p = 0.005), stratified analyses according to exposure to maternal smoking in-utero or indoor smoking at 10 yrs of age showed significant association (OR = 4.4, 95% CI 1.5-12.6, p = 0.006 and OR 5.6, 95% CI 1.7-18.5, p = 0.004, respectively) only in the non-exposed and not in exposed children. The SNP-BHR association was replicated in the non-tobacco-smoke-exposed subjects in one of the GAIN centers (BHR associated with the T allele (p = 0.034)), but not in the collated GAIN populations. Asthma, allergic sensitization, and lung function were not associated with the rs8034191 alleles.


CONCLUSIONS
An interaction between tobacco smoke exposure and a CHRNA3/5 polymorphism was found for BHR in children, but CHRNA3/5 was not associated with asthma or lung function.
National Centre for Epilepsy, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway. t.m.torjussen@medisin.uio.no
Tale M
TM
Torjussen
Karin C
KC
Lødrup Carlsen
Monica C
MC
Munthe-Kaas
Petter
P
Mowinckel
Kai-Håkon
KH
Carlsen
Peter J
PJ
Helms
Jorrit
J
Gerritsen
Moira K
MK
Whyte
Warren
W
Lenney
Dag E
DE
Undlien
Kevin V
KV
Shianna
Guohua
G
Zhu
Sreekumar G
SG
Pillai
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000209:etiology / Q000235:genetics; D016535:Bronchial Hyperreactivity / Q000235:genetics*; D002648:Child; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011978:Receptors, Nicotinic / Q000235:genetics*; D012129:Respiratory Function Tests; D012907:Smoking / Q000235:genetics*; D014797:Vital Capacity / Q000235:genetics; D055815:Young Adult
D009419:Nerve Tissue Proteins; D011978:Receptors, Nicotinic; C447158:CHRNA5 protein, human